Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment.

Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment. Ann Rheum Dis. 2011 Feb; 70(2):395-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.